Global law firm White & Case LLP has advised MidEuropa on the sale of leading European ophthalmology platform Optegra to EssilorLuxottica.
"Following MidEuropa's acquisition of Optegra in 2022, we have watched the company grow substantially," said White & Case partner Ken Barry, who co-led the Firm's deal team. "We are delighted to partner once again with our long-standing client MidEuropa, having advised them on their acquisition of Optegra and now its sale, which is testament to our team's wide capabilities, advising our clients at every stage of the investment lifecycle."
"Life sciences and healthcare have seen large volumes of activity recently, despite there being clear challenges in the market," said White & Case partner Joe Bradley. "Our industry-leading and integrated global team continues to advise some of the largest investors in the sector on their most significant transactions."
MidEuropa is central Europe's largest private equity firm and has a successful track record spanning more than 20 years, with over €6 billion assets under management and 44 businesses backed to date.
Optegra is a specialist provider of ophthalmic services. Established in 2007, it has completed over one million eye procedures from its 70 eye hospitals across the UK, Czechia, Poland, Slovakia and Holland.
The White & Case London team was led by partners Ken Barry and Joe Bradley and included partners Colin Harley, Nicola Jeffree, Michael Engel and Catherine Hill and associates Amelia Nichols, Ahmad Obeidat, Joao Lacerda, Jacob Heath and Alice Parsons.
Press contact
For more information please speak to your local media contact.
